Hidden bone loss: HIV and cancer patients under the scanner
NCT ID NCT04742387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why people with HIV and certain cancers caused by KSHV (Kaposi sarcoma herpesvirus) may lose bone density faster. Researchers will review past CT scans and health records from 40 adults treated at the NIH between 2005 and 2020. The goal is to find factors linked to bone loss, which can help guide future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IL-6 RELATED KSHV ASSOCIATED CYTOKINE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute (NCI)
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail targets rare, aggressive cancer
- New hope for HIV patients with aggressive lymphoma: early trial launches
- Kaposi's sarcoma drug trial halted early – what we know
- Scientists seek tissue samples to unlock HIV-Cancer mysteries
- New drug shows promise in blocking kaposi sarcoma growth
- Can a smaller dose of this cancer drug still work? new trial aims to find out